SHBG levels were increased non-significantly in women with PCOS who used LGD intervention vs. comparator groups, with a SMD of 0.6 (95% CI: -0.14 to 1.34, P = 0.11, I2 = 77%). This evidence concerns the gene SHBG and polycystic ovary syndrome.